The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial

scientific article published on 02 November 2020

The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/JCM9113536
P932PMC publication ID7693312
P698PubMed publication ID33147751

P50authorWolfgang G K Müller-LierheimQ97897420
Sultan Al-ZaaidiQ101223103
Osama Al-SheikhQ101223104
Berthold SeitzQ21140764
Christophe BaudouinQ37616711
P2093author name stringHerbert A Reitsamer
Oliver Stachs
Daniel Böhringer
Stefano Barabino
Jutta Horwath-Winter
Jose M Benitez-Del-Castillo
Ebru Toker
Gysbert-Botho van Setten
Ria Beck
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue11
P921main subjecteye diseaseQ3041498
P577publication date2020-11-02
P1433published inJournal of Clinical MedicineQ27724774
P1476titleThe HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial
P478volume9

Search more.